Growth patterns and gastrointestinal symptoms in pediatric patients after hematopoietic stem cell transplantation

Cheryl Rodgers1, Patricia Wills-Alcoser, Rebecca Monroe

  • 1Texas Children's Cancer Center and Hematology Service, Houston, USA. ccrodger@txccc.org

Insights

Pediatric patients undergoing hematopoietic stem cell transplantation (HSCT) show poor growth and experience gastrointestinal (GI) symptoms post-transplant. Acute graft-versus-host disease (GVHD) did not significantly impact growth or GI symptoms in this study.

Area of Science:

  • Pediatric Hematology/Oncology
  • Transplantation Medicine
  • Gastroenterology

Background:

  • Hematopoietic stem cell transplantation (HSCT) is a critical treatment for pediatric cancers and other diseases.
  • Understanding post-transplant recovery, including growth and gastrointestinal (GI) symptoms, is vital for patient outcomes.
  • The potential impact of acute graft-versus-host disease (GVHD) on these recovery parameters requires investigation.

Purpose of the Study:

  • To identify growth patterns in pediatric patients during the first four months after HSCT.
  • To characterize gastrointestinal (GI) symptoms experienced by these patients.
  • To assess the association between acute GVHD and changes in growth or GI symptoms.

Main Methods:

  • Prospective, longitudinal cohort study design.
  • Involved 35 pediatric patients undergoing allogeneic HSCT at a tertiary children's hospital.
  • Anthropometric measurements and GI symptom surveys were conducted before and at two and four months post-HSCT.

Main Results:

  • Significant changes in anthropometric measurements were observed; height increased, while weight and body composition decreased.
  • Eight GI symptoms were prevalent, with minimal fluctuation in severity and distress scores over four months.
  • No statistically significant differences in growth parameters or GI symptoms were found between patients with and without acute GVHD.

Conclusions:

  • Pediatric patients exhibit suboptimal growth patterns and persistent GI symptoms in the initial four months following HSCT.
  • Nurses play a crucial role in monitoring growth and symptom experience to optimize recovery plans for pediatric HSCT patients.
Abstract

Related Concept Videos

Assessment of the Gastrointestinal System II: Health Perception Pattern01:29

Assessment of the Gastrointestinal System II: Health Perception Pattern

Assessing the gastrointestinal (GI) system is a complex process that begins with collecting subjective data. This data, collected through patient interviews, provides crucial insights into the patient's health history, perception patterns, and lifestyle habits, all contributing significantly to GI health.
Health Perception Patterns
Health perception patterns offer valuable insights into a patient's lifestyle habits and how they may impact their GI health. These patterns include:
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Hematopoiesis01:21

Hematopoiesis

The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Role of Hematopoietic Growth Factors01:28

Role of Hematopoietic Growth Factors

Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
Overview of Hematopoiesis01:20

Overview of Hematopoiesis

Hematopoiesis, or blood cell production, is a vital biological process that begins early in embryonic development and continues throughout life. This process generates the various types of cells found in blood, including red blood cells, white blood cells, and platelets from hematopoietic stem cells (HSCs).
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...